BE825367A - Matrice de medicament pour liberation progressive - Google Patents

Matrice de medicament pour liberation progressive

Info

Publication number
BE825367A
BE825367A BE153217A BE153217A BE825367A BE 825367 A BE825367 A BE 825367A BE 153217 A BE153217 A BE 153217A BE 153217 A BE153217 A BE 153217A BE 825367 A BE825367 A BE 825367A
Authority
BE
Belgium
Prior art keywords
drug matrix
progressive release
progressive
release
drug
Prior art date
Application number
BE153217A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE825367A publication Critical patent/BE825367A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE153217A 1974-02-11 1975-02-10 Matrice de medicament pour liberation progressive BE825367A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US441695A US3911098A (en) 1974-02-11 1974-02-11 Medicament carrier

Publications (1)

Publication Number Publication Date
BE825367A true BE825367A (fr) 1975-08-11

Family

ID=23753927

Family Applications (1)

Application Number Title Priority Date Filing Date
BE153217A BE825367A (fr) 1974-02-11 1975-02-10 Matrice de medicament pour liberation progressive

Country Status (19)

Country Link
US (1) US3911098A (xx)
JP (1) JPS50123815A (xx)
AR (1) AR206618A1 (xx)
BE (1) BE825367A (xx)
CA (1) CA1045975A (xx)
CS (1) CS207808B1 (xx)
DD (1) DD118801A5 (xx)
DE (1) DE2505305A1 (xx)
ES (1) ES434618A1 (xx)
FR (1) FR2260356B1 (xx)
GB (1) GB1499751A (xx)
IL (1) IL46496A (xx)
IT (1) IT1036866B (xx)
NL (1) NL7501365A (xx)
PH (1) PH13485A (xx)
PL (1) PL177948A1 (xx)
RO (1) RO68711A (xx)
SE (1) SE7501464L (xx)
ZA (1) ZA75472B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4066747A (en) * 1976-04-08 1978-01-03 Alza Corporation Polymeric orthoesters housing beneficial drug for controlled release therefrom
JPS5441319A (en) * 1977-06-28 1979-04-02 Uni Sutorasukuraido Za Pharmaceutical composition for treating tropic desease
US4287175A (en) * 1978-06-22 1981-09-01 Merck & Co., Inc. Contact lens wetting agents
JPS57134412A (en) * 1981-02-12 1982-08-19 Unitika Ltd Biodegradable drug donor
DE3360633D1 (en) * 1982-02-12 1985-10-03 Unitika Ltd Anti-cancer device
US5277900A (en) * 1982-08-07 1994-01-11 Henkel Kommanditgesellschaft Auf Aktien Method for blood coagulation on hard tissues
JPS6036410A (ja) * 1983-08-08 1985-02-25 Unitika Ltd 生分解性薬物供与体の製造方法
JPH0623091B2 (ja) * 1984-03-16 1994-03-30 ユニチカ株式会社 キチン成形体の製造法
US5290752A (en) * 1984-03-16 1994-03-01 Unitika Ltd. Method for preparation of a shaped chitin body containing a physiologically active substance
JPS62193638A (ja) * 1986-02-20 1987-08-25 Kao Corp 顆粒剤
US4931551A (en) * 1988-07-05 1990-06-05 University Of Delaware Dispersions of chitin and product therefrom
AU2572692A (en) 1991-09-09 1993-04-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and devices for treating hemophilia and aids
US5383873A (en) * 1992-12-09 1995-01-24 Regents Of The University Of Minnesota Smooth muscle chemical pacemaker
US5741329A (en) * 1994-12-21 1998-04-21 Board Of Regents, The University Of Texas System Method of controlling the pH in the vicinity of biodegradable implants
US6065476A (en) * 1994-12-21 2000-05-23 Board Of Regents, University Of Texas System Method of enhancing surface porosity of biodegradable implants
US6767899B1 (en) 2000-08-29 2004-07-27 Leiner Health Services Corp. Composition and method for treatment of conditions having an inflammatory component
US7018646B2 (en) * 2002-05-30 2006-03-28 Van Dalen Johan T W Apparatus and method for delivering controlled quantities of one or more agents to the eye
US7699863B2 (en) * 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US7785291B2 (en) * 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
WO2013183058A2 (en) 2012-06-07 2013-12-12 Tulip Medical Ltd. Expanded device
US9320645B2 (en) 2013-05-29 2016-04-26 Terry Glasser Approach to administering ocular medication
ES2926480T3 (es) 2013-12-05 2022-10-26 Epitomee Medical Ltd Dispositivos y sistemas retentivos para la liberación in situ de principios activos farmacéuticos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2040879A (en) * 1934-06-21 1936-05-19 Du Pont Substantially undegraded deacetylated chitin and process for producing the same
US2040880A (en) * 1934-06-21 1936-05-19 Du Pont Process for the preparation of films and filaments and products thereof
US2168374A (en) * 1936-07-09 1939-08-08 Visking Corp Chemical compounds and products produced therefrom
US3632754A (en) * 1968-02-12 1972-01-04 Lescarden Ltd Use of chitin for promoting wound healing
US3736646A (en) * 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US3845201A (en) * 1972-04-24 1974-10-29 S Loucas Solid state ophthalmic medication delivery method

Also Published As

Publication number Publication date
JPS50123815A (xx) 1975-09-29
IT1036866B (it) 1979-10-30
FR2260356B1 (xx) 1978-07-28
GB1499751A (en) 1978-02-01
US3911098A (en) 1975-10-07
AR206618A1 (es) 1976-08-06
PL177948A1 (en) 1978-04-10
SE7501464L (xx) 1975-08-12
AU7760275A (en) 1976-07-29
IL46496A (en) 1978-08-31
IL46496A0 (en) 1975-06-25
ZA75472B (en) 1976-01-28
CS207808B1 (en) 1981-08-31
NL7501365A (nl) 1975-08-13
DD118801A5 (xx) 1976-03-20
RO68711A (ro) 1980-10-30
FR2260356A1 (xx) 1975-09-05
CA1045975A (en) 1979-01-09
ES434618A1 (es) 1977-04-16
PH13485A (en) 1980-05-21
DE2505305A1 (de) 1975-08-21

Similar Documents

Publication Publication Date Title
BE825367A (fr) Matrice de medicament pour liberation progressive
BE765435A (fr) Ensemble de remplissage pour medicament
BE833762A (fr) Supports pour medicaments
IL43839A0 (en) Compositions for sustained release of a medicament
ZA714095B (en) Bandage for administering drugs
ZA746099B (en) Zero-order release device
IL39430A (en) Slow release pharmaceutical compositions
FR2288513A1 (fr) Presentations pour substances pharmaceutiques
NZ180321A (en) Sustained release pharmaceutical preparation
NZ177941A (en) Cross linked hydrophilic copolymers-bodyimplantssustained release matrix for spcific agents
FR2326933A1 (fr) Comprime a liberation controlee de medicament
BE811386A (fr) Medicament microencapsule
IL46196A0 (en) Intra-uterine contraceptive device
AT342776B (de) Hartwandige kapseln fur medikamente
BE789524A (fr) Dispositif de liberation de medicaments
FR2274275A1 (fr) Capsule, notamment pour medicaments
IT1027134B (it) Dispositivo distacco frizione
IT1002833B (it) Dispositivo di frenatura per veico li
SE7512570L (sv) Beskickningsanordning for vulkpressar
BE773113A (fr) Composition pharmaceutique a liberation progressive de la substance active
ZA725506B (en) Sustained release pharmaceutical tablet
IL32200A0 (en) Sustained release drug composition
BE757586A (fr) Forme pharmaceutique a liberation programmee de la substance active
SE384464B (sv) Anordning vid tryckgjutningsmaskiner for efterfyllning av gjutmassa
CH535660A (fr) Machine à relier